Glaukos (NYSE:GKOS – Free Report) had its price objective boosted by Wells Fargo & Company from $153.00 to $160.00 in a ...
Insulet (NASDAQ:PODD – Get Free Report) had its target price upped by equities researchers at Wells Fargo & Company from $305 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results